Progesterone mimic plus anti-estrogen treatment slows tumor growth in breast cancer patients
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found.